has reported that he has no relationships relevant to the contents of this paper to disclose. As an inevitable limitation of long-term follow-up stent studies, one-half of the stents used in this study
were first-generation drug-eluting stents, which are not used in current daily practice. As newer generation stents work better than previous ones, especially for complex lesions, the results of this study should be interpreted in the context of this limitation (8, 9) .
Although there was no interaction between treatment strategy and clinical outcomes across stent types, the use of second-generation drug-eluting stents was independently associated with lower rates of target vessel failure at 3 years in this study. 
